CardieX Limited (ASX:CDX)

Australia flag Australia · Delayed Price · Currency is AUD
0.0390
-0.0010 (-2.50%)
Jul 4, 2025, 10:41 AM AEST
-38.10%
Market Cap 21.45M
Revenue (ttm) 5.72M
Net Income (ttm) -14.55M
Shares Out 550.08M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 57,176
Average Volume 372,236
Open 0.0400
Previous Close 0.0400
Day's Range 0.0390 - 0.0400
52-Week Range 0.0380 - 0.1750
Beta 1.12
RSI 38.00
Earnings Date Aug 29, 2025

About CardieX

CardieX Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; an... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1994
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol CDX
Full Company Profile

Financial Performance

In 2024, CardieX's revenue was 12.81 million, an increase of 125.14% compared to the previous year's 5.69 million. Losses were -6.77 million, -64.18% less than in 2023.

Financial Statements

News

There is no news available yet.